Skip to main content
logo
Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ: REGN · Real-Time Price · USD
904.35
+1.45 (0.16%)
At close: Nov 6, 2026, 4:00 PM EST
900.92
-3.43 (-0.38%)
After-hours: Nov 6, 2026, 7:58 PM EST

Regeneron Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Operating Revenue
4,8064,0973,4343,6463,5563,4922,9473,6103,6073,4433,0283,2223,2243,0893,0463,2872,8522,7982,8714,866
Other Revenue
310193.3171.2238.6198.2183.981.9179.4114.2104.5116.9212.5138.369.3116127.784.259.29486.2
Revenue
5,1164,2913,6053,8843,7543,6763,0293,7893,7213,5473,1453,4343,3633,1583,1623,4142,9362,8572,9654,952
Revenue Growth (YoY)
36.27%16.73%19.04%2.51%0.90%3.62%-3.70%10.33%10.65%12.32%-0.54%0.58%14.53%10.53%6.64%-31.05%-14.96%-44.40%17.26%104.37%
Cost of Revenue
2,3682,2082,2132,2111,9971,9521,7921,9781,7631,6801,6821,6941,5121,4901,5591,5841,2291,0911,2491,720
Gross Profit
2,7482,0831,3931,6741,7581,7241,2371,8121,9581,8671,4631,7401,8511,6681,6031,8311,7071,7661,7163,232
Selling, General & Admin
677.8662.1647.7775657.8634.2633792.2714.4758.8689737.7640.5652601.1660.5529.1476.3450559.6
Other Operating Expenses
-----10-------0.5-0.5-0.6-0.5-6.6-45.7-17.4-20.2-15.8
Operating Expenses
677.8662.1647.7775647.8634.2633792.2714.4758.8689737.2640651.4600.6653.9483.4458.9429.8543.8
Operating Income
2,0701,421744.8898.61,1101,0906041,0201,2441,108773.81,0031,2111,0171,0031,1771,2241,3071,2872,688
Interest Expense
-10.6-11-12.9-12.2-19.3-3.6-8.7-10.5-13.8-14.8-16.1-18.3-17.8-18.9-18-17.4-15.3-13.1-13.6-14.1
Interest & Investment Income
181.8183.3183.5193.3175.1174.8173.5183.1187.4179.4161.5148.7133.7118.395.270.542.928.2-45.8
Currency Exchange Gain (Loss)
---2.4----0.6----12.9---50.2----
Other Non Operating Income (Expenses)
4.40.1-7.3958.53188.69.45.21.40.1-0.913.2-2.1-1.2-6.24.21.927.4-30.3
EBT Excluding Unusual Items
2,2451,593908.12,0411,2691,279777.41,2011,4231,274919.31,1201,3401,1141,0791,2741,2561,3241,3002,689
Gain (Loss) on Sale of Investments
60.361.925-978.2577.7250139.9-213.5134.7392.5-196.258.1-129.3-30.9-164.780.8254.3-163.7-211.2-137.7
Other Unusual Items
--------15.5-8-14.6-15.3---------
Pretax Income
2,2841,528831.21,0441,7631,519905958.11,4931,628700.71,1481,1111,0838581,3251,510963.21,0612,503
Income Tax Expense
335.4230.9104199.1303.3127.196.340.4152.4195.8-21.3-12103114.540.2127.6194.1111.187.6274.4
Net Income
1,9491,297727.2844.61,4601,392808.7917.71,3411,4327221,1601,008968.4817.81,1971,316852.1973.52,229
Net Income to Common
1,9491,297727.2844.61,4601,392808.7917.71,3411,4327221,1601,008968.4817.81,1971,316852.1973.52,229
Net Income Growth (YoY)
33.47%-6.80%-10.08%-7.97%8.91%-2.84%12.01%-20.86%33.02%47.90%-11.71%-3.13%-23.40%13.65%-15.99%-46.29%-19.39%-72.50%-12.71%93.96%
Shares Outstanding (Basic)
102103104103104105107108108108108107106107107107107108107106
Shares Outstanding (Diluted)
106106108108107109111114116115115114113114114114113114113113
Shares Change (YoY)
-1.49%-2.39%-3.15%-5.54%-7.75%-5.89%-3.39%-2.47%1.32%0.97%-0.18%0.53%-0.09%0.80%0.71%-0.97%2.89%2.35%0.89%
EPS (Basic)
19.1612.626.998.2114.0913.247.588.5312.4013.256.7010.889.489.057.6411.1912.317.909.1220.99
EPS (Diluted)
18.4512.236.757.8613.6212.817.278.0711.5412.416.2710.198.898.507.1710.4911.667.478.6119.69
EPS Growth (YoY)
35.46%-4.53%-7.15%-2.64%18.02%3.22%15.95%-20.81%29.81%46.00%-12.55%-2.87%-23.76%13.79%-16.73%-46.71%-18.63%-73.29%-14.67%92.27%

Additional Metrics

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Free Cash Flow
1,483572.8848.39221,417925.4815.81,0631,049173.51,379838.3938.3909.41,1891,568486.4410.81,9602,218
Free Cash Flow Per Share
14.045.407.888.5813.228.527.349.349.031.5011.987.378.277.9810.4313.754.313.6017.3319.59
Dividend Per Share
0.9400.9400.9400.8800.8800.8800.880-------------
Dividend Growth (YoY)
6.82%6.82%6.82%-----------------
Gross Margin
53.71%48.54%38.62%43.09%46.82%46.90%40.84%47.81%52.63%52.63%46.51%50.67%55.05%52.81%50.71%53.62%58.14%61.80%57.89%65.26%
Operating Margin
40.46%33.11%20.66%23.13%29.56%29.64%19.94%26.91%33.43%31.24%24.60%29.20%36.01%32.19%31.71%34.47%41.68%45.74%43.39%54.28%
Profit Margin
38.09%30.23%20.17%21.74%38.89%37.86%26.70%24.22%36.03%40.38%22.96%33.77%29.97%30.66%25.86%35.06%44.81%29.82%32.83%45.02%
Free Cash Flow Margin
28.99%13.35%23.53%23.74%37.75%25.18%26.94%28.06%28.20%4.89%43.84%24.41%27.90%28.80%37.61%45.91%16.57%14.38%66.10%44.79%
EBITDA
2,1911,5448681,0441,2471,225730.91,1461,3651,229887.91,1161,3161,1201,1021,2771,3161,3811,3612,762
EBITDA Margin
42.82%35.99%24.07%26.87%33.20%33.32%24.13%30.24%36.70%34.64%28.23%32.49%39.15%35.45%34.86%37.40%44.83%48.34%45.90%55.78%
D&A For EBITDA
121123.7123.2145136.7135.1126.9126.4121.7120.7114.1113105.4103.199.5100.192.674.474.374.5
EBIT
2,0701,421744.8898.61,1101,0906041,0201,2441,108773.81,0031,2111,0171,0031,1771,2241,3071,2872,688
EBIT Margin
40.46%33.11%20.66%23.13%29.56%29.64%19.94%26.91%33.43%31.24%24.60%29.20%36.01%32.19%31.71%34.47%41.68%45.74%43.39%54.28%
Effective Tax Rate
14.68%15.11%12.51%19.08%17.20%8.37%10.64%4.22%10.21%12.03%--9.27%10.57%4.69%9.63%12.86%11.53%8.25%10.96%
Revenue as Reported
5,1164,2913,6053,8843,7543,6763,0293,7893,7213,5473,1453,4343,3633,1583,1623,4142,9362,8572,9654,952
SEC Filings: 10-K · 10-Q